ARA-C, IDARUBICINE AND GENTUZUMAB OZOGAMICIN (AIM) AS SALVAGE TREATMENT IN ADVANCED ACUTE MYELOID LEUKEMIA PATIENTS. (2012). Mediterranean Journal of Hematology and Infectious Diseases, 4(1), e2012072. https://doi.org/10.4084/mjhid.2012.072